MAPT and Alzheimer disease: Several previous reports suggest a relevance between opioid receptors and changes in AD pathology/behaviors, including alterations in cognition, hyperphosphorylated tau, Aβ production, and neuro-inflammation (Meilandt et al., 2008; Cai and Ratka, 2012).